Geoff Birkett
2023
In 2023, Geoff Birkett earned a total compensation of $392.4K as Chief Commercial Officer at Ensysce Biosciences, a 7% increase compared to previous year.
Compensation breakdown
| Option Awards | $70,350 |
|---|---|
| Salary | $312,625 |
| Other | $9,379 |
| Total | $392,354 |
Birkett received $312.6K in salary, accounting for 80% of the total pay in 2023.
Birkett also received $70.4K in option awards and $9.4K in other compensation.
Rankings
In 2023, Geoff Birkett's compensation ranked 2,233rd out of 2,878 executives tracked by ExecPay. In other words, Birkett earned more than 22.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,233 out of 2,878 | 22nd |
Division Manufacturing | 1,257 out of 1,582 | 21st |
Major group Chemicals And Allied Products | 750 out of 891 | 16th |
Industry group Drugs | 731 out of 854 | 14th |
Industry Pharmaceutical Preparations | 524 out of 614 | 15th |
Source: SEC filing on October 17, 2024.
Birkett's colleagues
We found two more compensation records of executives who worked with Geoff Birkett at Ensysce Biosciences in 2023.
News
Ensysce Biosciences CEO Lynn Kirkpatrick's 2023 pay slips 18% to $509K
October 17, 2024
Ensysce Biosciences CFO David Humphrey's 2022 pay jumps 175% to $781K
July 13, 2023
Ensysce Biosciences CEO Lynn Kirkpatrick's 2021 pay jumps 85% to $288K
May 2, 2022
Ensysce Biosciences CEO D Kirkpatrick receives $156K in 2020
December 17, 2021